Mental and behavioural disorders Mental and Behavioural Disorders
Conditions
Interventions
Current interventions as of 24/04/2012
Arm 1: CCBT + MCBT + MCI control
Arm 2: CCBT + MCBT control + MCI
Arm 3: CCBT + MCBT control + MCI control
MCBT: CBT for maternal anxiety disorder
This will
eight with the mother alone and two
with the mother and child together. This is a novel intervention which specifically targets anxiogenic features of the mother-child relationship. Specifically it a
Sponsors
University of Reading (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Current inclusion criteria as of 21/03/2012 Child: 1. Aged 7 to 12 years 2. Primary diagnosis of DSM-IV generalised anxiety disorder, social phobia, separation anxiety disorder , panic disorder/agoraphobia or specific phobia, co-morbid with one of the previous disorders 3. Absence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Primary carer 2. Current maternal DSM-IV anxiety disorder 3. Absence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Absence of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study) Previous inclusion criteria Child: 1. Aged 7 to 12 years 2. Primary diagnosis of Diagnostic and Statistical Manual of Mental Disorders - fourth edition (DSM-IV) generalised anxiety disorder, social phobia, or separation anxiety disorder 3. Absence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Primary carer 2. Current maternal DSM-IV anxiety disorder 3. Absence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Absence of psychotropic medication (or, if psychotropic medication is prescribed, it should have been at a stable dose for at least one month with agreement to maintain that dose throughout the study)
Exclusion criteria
Exclusion criteria: Child: 1. Aged less than 7 or over 12 years 2. No primary diagnosis of DSM-IV generalised anxiety disorder, social phobia, or separation anxiety disorder 3. Presence of significant physical or intellectual impairment (including autistic spectrum disorders) Mother: 1. Is not primary carer 2. Absence of current maternal DSM-IV anxiety disorder 3. Presence of severe comorbid disorder (e.g. severe major depressive disorder, psychosis, substance/alcohol dependence) For both the mother and child: Presence of psychotropic medication at a stable dose for less than one month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome is child anxiety (assessed both categorically [i.e. diagnosis] and continuously [i.e. symptoms]). Diagnostic status will be assessed by the Anxiety Disorders Interview Schedule (ADIS) for DSM-IV: C/P administered to both the mother and child. Assessors will be blind to treatment condition. Assessors' beliefs about treatment condition will be formally assessed. Child anxiety symptoms will be assessed using questionnaires (Spence Children's Anxiety Scale [SCAS]) administered to the child, the mother and the child's teacher. These measures will be administered post-treatment, and at 6 and 12 month follow-up assessments. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Maternal anxiety, assessed categorically using the ADIS (DSM-IV) post-treatment, and at 6- and 12-month follow-up assessments 2. Maternal anxiety, assessed continuously using the following questionnaires post-treatment, and at 6- and 12-month follow-up assessments: 2.1. Depression Anxiety and Stress Scales (DASS) 2.2. Penn State Worry Questionnaire (PSWQ) 2.3. Social Interaction Anxiety Scale (SIAS) 2.4. Social Phobia Scale (SPS) 3. Maternal interactive behaviours will be assessed by filming the mother assisting the child perform an anxiety provoking task and applying standardised ratings of anxiogenic behaviours (i.e. modelling, lack of encouragement, overcontrol/overprotection). Interactive behaviours will be coded by independent, trained, reliable raters. Coders will be blind to the purpose and conditions of the trial. Maternal cognitions will be assessed by a standardised interview. These measures will be conducted at the post-treatment assessment. | — |
Countries
United Kingdom
Outcome results
None listed